Get the Stockscreener App
2.57
1.72%
-0.05
Elutia Inc stock is traded at $2.57, with a volume of 13,544.
It is down -1.72% in the last 24 hours and down -24.26% over the past month.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
See More
Previous Close:
$2.62
Open:
$2.52
24h Volume:
13,544
Relative Volume:
0.35
Market Cap:
$105.02M
Revenue:
$24.99M
Net Income/Loss:
$-65.24M
P/E Ratio:
-0.8986
EPS:
-2.86
Net Cash Flow:
$-21.27M
1W Performance:
-20.03%
1M Performance:
-24.26%
6M Performance:
-9.33%
1Y Performance:
-31.33%
1-Day Range:
$2.50
$2.59
1-Week Range:
$2.50
$3.0799
52-Week Range:
$2.28
$5.24
Elutia Inc Stock (ELUT) Company Profile
Name
Elutia Inc
Sector
Industry
Phone
240-247-1143
Address
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
2.56 | 105.02M | 24.99M | -65.24M | -21.27M | -2.86 |
|
ABT
Abbott Laboratories
|
128.90 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.46 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
392.20 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.88 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.92 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-02-20 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-02-20 | Initiated | Cowen | Outperform |
| Nov-02-20 | Initiated | Piper Sandler | Overweight |
| Nov-02-20 | Initiated | Truist | Buy |
Elutia Inc Stock (ELUT) Latest News
Aziyo Biologics Announces Strategic Financial Offering - TipRanks
Elutia Inc. (NASDAQ:ELUT) Short Interest Up 29.8% in January - MarketBeat
Elutia Inc. secures $15 million through stock and warrant sale - Investing.com India
Elutia Inc. reports mixed preliminary 2024 financial results By Investing.com - Investing.com Australia
Elutia launches $15M securities offering - MSN
Elutia Announces $15.0 Million Registered Direct Offering - citybiz
Elutia Inc. reports mixed preliminary 2024 financial results - Investing.com India
Elutia to Raise Roughly $15 Million Through Registered Direct Offering -February 03, 2025 at 09:09 am EST - Marketscreener.com
Elutia Inc. Provides Sales Guidance for the Year Ended December 31, 2024 -February 03, 2025 at 06:08 am EST - Marketscreener.com
Medical Device Maker Elutia Secures Crucial $15M Funding Round: Strategic Growth Move - StockTitan
SEC Form 424B5 filed by Elutia Inc. - Quantisnow
Cantor Fitzgerald Raises Earnings Estimates for Elutia - Defense World
Cantor Fitzgerald Forecasts Increased Earnings for Elutia - MarketBeat
Cantor Fitzgerald Predicts Elutia FY2025 Earnings - Defense World
Elutia announces full U.S. commercial launch of EluPro - Yahoo Finance
Elutia Inc. Announces Full Launch of EluPro? Following Strong Initial Demand -January 14, 2025 at 08:00 am EST - Marketscreener.com
Elutia Announces Full Launch of EluPro™ Following Strong Initial Demand - The Manila Times
Elutia Inc. (NASDAQ:ELUT) Stock Position Lifted by Geode Capital Management LLC - Defense World
Elutia secures deal to supply antibiotic bioenvelope By Investing.com - Investing.com Australia
Elutia Announces EluPro™ GPO Agreement with Southern Strategic Sourcing Partners - The Manila Times
Elutia secures deal to supply antibiotic bioenvelope - Investing.com
Elutia's Revolutionary EluPro Antibiotic Device Gains Access to 993 Healthcare Facilities - StockTitan
Elutia Inc. (NASDAQ:ELUT) Not Doing Enough For Some Investors As Its Shares Slump 27% - Simply Wall St
Are Medical Stocks Lagging ELUTIA INC (ELUT) This Year? - Yahoo Finance
Elutia (NASDAQ:ELUT) Trading 1.9% HigherHere's Why - MarketBeat
Elutia (NASDAQ:ELUT) Trading Up 1.9% – Here’s Why - Defense World
Elutia awarded cardian rhythm management devices agreement with Premier - TipRanks
Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc. - The Manila Times
ELUTElutia Inc. Latest Stock News & Market Updates - StockTitan
Elutia Inc. (NASDAQ:ELUT) Held Back By Insufficient Growth Even After Shares Climb 26% - Simply Wall St
Elutia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Elutia Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Cantor Fitzgerald Reaffirms Overweight Rating for Elutia (NASDAQ:ELUT) - Defense World
Elutia's (ELUT) "Overweight" Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Elutia Inc (ELUT) Q3 2024 Earnings Call Highlights: Strategic Gr - GuruFocus.com
Elutia Inc (ELUT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges By GuruFocus - Investing.com Canada
Elutia Inc. (ELUT) Quarterly 10-Q Report - Quartzy
Elutia Inc. Reports Strong Q3 Results, Prepares for Major Product Launch - TipRanks
Elutia Inc (ELUT) Q3 2024 Earnings: EPS of $0.03 Beats Estimates, Revenue of $5.92M Misses Expectations - GuruFocus.com
Elutia earnings beat by $0.11, revenue fell short of estimates - Investing.com UK
Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025 - The Manila Times
Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - The Manila Times
What To Expect From Elutia Inc (ELUT) Q3 2024 Earnings - GuruFocus.com
Elutia Inc Stock (ELUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Elutia Inc Stock (ELUT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ferguson Matthew | CHIEF FINANCIAL OFFICER |
Mar 08 '24 |
Option Exercise |
0.00 |
1,288 |
0 |
121,807 |
1.29%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):